Canada NewsWire WHITEHORSE, YT, March 20, 2025 WHITEHORSE, YT, March 20, 2025 /CNW/ - No one should have to choose between paying for prescription drugs and putting food on the table. That's why the Government of Canada is taking action so ...
PR Newswire STRASBOURG, France, MONTREAL, BOSTON, March 20, 2025 STRASBOURG, France, MONTREAL, BOSTON, March 20, 2025 /PRNewswire/ -- Domain Therapeutics ("Domain" or "the Company"), the GPCR experts harnessing deep receptor biology to ...
PR Newswire NEW YORK, March 18, 2025 NEW YORK, March 18, 2025 /PRNewswire/ -- Small amounts of a common antibiotic and anti-inflammatory drug can curb symptoms where a misplaced immune reaction (e.g., autoimmunity) can cause permanent hair ...
PR Newswire SAN DIEGO, March 17, 2025 SAN DIEGO, March 17, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) presented data from the KINECT®-HD study showcasing significant improvements in chorea across body regions with ...
PR Newswire CONCORD, Mass., March 17, 2025 Seven abstracts highlight long-term effects, consistent safety profile, and delayed disease progression with givinostat Results also show that treatment is associated with delayed decline in ...
PR Newswire NEW YORK, March 17, 2025 NEW YORK, March 17, 2025 /PRNewswire/ -- GRIN Therapeutics, Inc., a leader in the development of therapies to treat serious neurodevelopmental disorders, today announced that the U.S. Food and Drug ...
Canada NewsWire TORONTO, March 17, 2025 TORONTO, March 17, 2025 /CNW/ - Biogen Canada Inc. is pleased to announce that Health Canada has approved SKYCLARYS™ (omaveloxolone) for the treatment of Friedreich's ataxia (FA) in patients 16 years ...
PR Newswire BRIDGEWATER, N.J., March 14, 2025 BRIDGEWATER, N.J., March 14, 2025 /PRNewswire/ -- Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the ...
PR Newswire SAN FRANCISCO and SUZHOU, China, March 14, 2025 SAN FRANCISCO and SUZHOU, China, March 14, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, ...
Canada NewsWire WHITEHORSE, YT, March 13, 2025 Agreement will improve access and affordability of drugs for rare diseases WHITEHORSE, YT, March 13, 2025 /CNW/ - In Canada, one in 12 people live with a rare disease and for most people ...
Lecanemab use is higher among white, male, urban, and wealthier patients despite broad Medicare coverage.
New antifungal nanotechnology uses targeted liposomes to boost drug delivery and fight Candida infections.
Real-world evidence shows long-term use of oral and inhaled steroids increases the risk of adrenal insufficiency, highlighting the need for proper treatment alternatives.
Legalizing and increased consumption of cannabis has led to increased cases of people visiting hospitals, many due to anxiety, psychosis, and other mental health disorders.
Glucagon-like peptide-1 receptor agonists improve cardiovascular outcomes and reduce mortality in patients with type 2 diabetes.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are provided for informational and educational purposes only. They should NOT be used for the diagnosis or treatment of any health-related condition or disease. Always consult a qualified healthcare professional for medical advice, diagnosis, or treatment. Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers